Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer settles Rezulin product liability litigation

Executive Summary

Pfizer has settled thousands of personal injury claims alleging the diabetes drug Rezulin (troglitazone) caused liver damage. The number of claims and the size of the settlement are confidential. However, Bloomberg reported that the company is paying $750 million to settle 35,000 claims. The company had set aside $975 million in 2003 for the litigation. Pfizer said the multidistrict litigation is now resolved and there are only a handful of cases remaining in state court, which it expects will be dismissed. Pfizer withdrew Rezulin from the market in 2000 after people taking the drug experienced liver failure
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS050916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel